HomeCompareBBMPY vs JNJ

BBMPY vs JNJ: Dividend Comparison 2026

BBMPY yields 9.10% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BBMPY wins by $234676.62M in total portfolio value
10 years
BBMPY
BBMPY
● Live price
9.10%
Share price
$1.52
Annual div
$0.14
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$234676.65M
Annual income
$229,824,952,588.51
Full BBMPY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — BBMPY vs JNJ

📍 BBMPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBBMPYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BBMPY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BBMPY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BBMPY
Annual income on $10K today (after 15% tax)
$773.50/yr
After 10yr DRIP, annual income (after tax)
$195,351,209,700.23/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, BBMPY beats the other by $195,351,205,714.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BBMPY + JNJ for your $10,000?

BBMPY: 50%JNJ: 50%
100% JNJ50/50100% BBMPY
Portfolio after 10yr
$117338.34M
Annual income
$114,912,478,638.96/yr
Blended yield
97.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BBMPY
No analyst data
Altman Z
0.6
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BBMPY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBBMPYJNJ
Forward yield9.10%2.13%
Annual dividend / share$0.14$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$234676.65M$30.3K
Annual income after 10y$229,824,952,588.51$4,689.40
Total dividends collected$234347.15M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BBMPY vs JNJ ($10,000, DRIP)

YearBBMPY PortfolioBBMPY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,520$1,820.00$10,592$272.30+$1.9KBBMPY
2$17,656$4,259.14$11,289$357.73+$6.4KBBMPY
3$30,118$11,226.51$12,123$472.89+$18.0KBBMPY
4$68,022$35,796.07$13,141$629.86+$54.9KBBMPY
5$223,899$151,114.91$14,408$846.81+$209.5KBBMPY
6$1,169,296$929,724.16$16,021$1,151.60+$1.15MBBMPY
7$10,326,699$9,075,552.76$18,122$1,588.22+$10.31MBBMPY
8$160,864,963$149,815,394.96$20,930$2,228.20+$160.84MBBMPY
9$4,534,295,602$4,362,170,090.90$24,792$3,191.91+$4534.27MBBMPY
10$234,676,648,882$229,824,952,588.51$30,274$4,689.40+$234676.62MBBMPY

BBMPY vs JNJ: Complete Analysis 2026

BBMPYStock

BBMG Corporation, an investment holding company, engages in manufacturing and sale of cement and building materials in Asia, Europe, Africa, and internationally. The company's Cement and Ready-Mixed Concrete segment manufactures and sells cement and concrete. Its Modern Building Materials and Commerce and Logistics segment produces furniture and woods, decorative and fitting materials, and wall body and insulation materials; and offers commerce and logistics services. The company's Property Development segment develops and sells housing properties. Its Property Investment and Management segment invests in properties; and provides management and security services to residential and commercial properties. The company offers mortars and crushed stones, slag fine powders, coatings and construction hardware, glass made spectacle lenses, glass wool products, wood based panels, resins, building materials, limestone and cement clinkers, refractory materials and ceramics, aerated concrete products, machinery equipment and accessories, wind power equipment, doors and windows, and sanitary ceramics; wholesales coal, building and metal materials, and metal and metallic minerals; and imports and exports bulk commodities. It provides project and furniture decoration, construction contracting and project management, accommodation and conference, hotel management, finance leasing, property consultancy, property rental, technology development, goods transportation and storage, waste disposal, finance and financing advisory, exhibition, tourism, and knitting processing services; offers loading, offloading, and handling services; provides building material testing services; and operates sports projects, as well as publishes concrete world magazine, and provides advertising design and production services. The company was founded in 2005 and is headquartered in Beijing, the People's Republic of China.

Full BBMPY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BBMPY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BBMPY vs SCHDBBMPY vs JEPIBBMPY vs OBBMPY vs KOBBMPY vs MAINBBMPY vs ABBVBBMPY vs MRKBBMPY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.